Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Clinical Immunology

The Biology of ITK Deficiency and Its Look-Alikes

At a Glance

ITK deficiency weakens the signals T cells need to multiply and coordinate an immune response, leaving children especially vulnerable to EBV. Genetic sequencing, flow cytometry, and functional tests help distinguish it from similar inherited immune disorders.

Understanding the biology of ITK deficiency helps explain why your child’s immune system responds differently to the world. It is not that their immune system is “off,” but rather that its internal communication system is malfunctioning. This page explains the mechanics of the ITK kinase and how doctors distinguish it from other similar conditions.

The ITK Kinase: The Immune System’s Volume Dial

In a healthy immune system, T-cells use receptors on their surface to “feel” for germs. When a T-cell finds a virus, it needs to send a signal to the rest of the cell to wake up and fight. The ITK kinase (a type of signaling protein) acts like a volume dial for this signal [1][2].

When the ITK protein is working, it helps the cell translate a weak signal into a strong response. It works within a complex of other proteins (like SLP-76 and PLC-γ1) to trigger essential functions:

  • Calcium Signaling: ITK helps release calcium inside the cell, which is required for the T-cell to multiply [3][4].
  • Gene Activation: It helps turn on the instructions needed to produce IL-2, a chemical that acts as “fuel” for immune cell growth [5][2].

In your child’s case, the missing or broken ITK protein means the volume dial is stuck on “low.” The T-cells might detect a threat like a virus, but the internal signal is too weak to trigger a full-scale defense [4][6].

Effects on Specific Immune Cells

ITK deficiency doesn’t affect all immune cells equally. It creates a specific pattern of “missing” or “misbehaving” cells:

  1. iNKT Cells (Invariant Natural Killer T-cells): These are specialized “scout” cells. In many children with ITK deficiency, these cells are nearly absent [4][7]. Without scouts, the immune system is slower to recognize certain viruses.
  2. CD4+ T-cells (Helper Cells): These cells coordinate the immune response. Children with this condition often have low CD4 counts (lymphopenia) and may struggle to produce the right cytokines (immune messengers) to fight infections [6][8].
  3. Treg Cells (Regulatory T-cells): These cells act as the immune system’s “brakes” to prevent it from attacking the body itself. In ITK deficiency, the balance of these cells can be unpredictable—sometimes they are too low, and sometimes they may actually increase, leading to a complex immune environment [6][9].
  4. CD8+ T-cells (Killer Cells): While these cells are present, they are often “clumsy.” They may have trouble multiplying or releasing the chemicals needed to kill infected cells [10][11].

The EBV Vulnerability

The Epstein-Barr Virus (EBV) is the primary threat for children with ITK deficiency. Normally, killer T-cells expand rapidly to eliminate EBV-infected cells. Because ITK-deficient T-cells cannot “turn up the volume” on their signals, they fail to multiply fast enough to catch the virus [12][11]. This allows EBV to live and grow inside B-cells, potentially leading to severe inflammation (HLH) or cancers like lymphoma [11][4].

Looking for “Look-Alikes”

Because several rare genetic disorders cause similar problems with EBV, doctors must perform a differential diagnosis—a process of elimination to ensure they are treating the right condition. Note: this table is educational; flow cytometry alone does not diagnose these without genetic and functional confirmation by an expert.

Condition Gene Involved Inheritance Key Differences from ITK
ITK Deficiency ITK Autosomal Recessive Causes low CD4 cells and unique signaling defects [13][6].
XLP1 SH2D1A X-linked (Predominantly Boys) Caused by a lack of the SAP protein; leads to severe “mono” and high risk of B-cell lymphoma. Can occasionally affect females [14][15].
XIAP Deficiency XIAP X-linked (Predominantly Boys) Very high risk of HLH and inflammatory bowel disease (Crohn-like symptoms) [16][17].
CD27 Deficiency CD27 Autosomal Recessive Caused by a lack of a specific “docking” protein on the cell surface; usually requires genetic testing, as low CD27 on flow cytometry alone is not definitive [18][19].
CD70 Deficiency CD70 Autosomal Recessive Similar to CD27 deficiency; the T-cells themselves may look normal, but they cannot “talk” to infected B-cells properly [20][21].

To distinguish these, your doctor will use genetic sequencing to find the specific mutation and flow cytometry alongside functional assays [6][22]. Knowing the exact genetic “address” of the problem is essential for planning the best treatment.

Common questions in this guide

What does ITK deficiency do to the immune system?
ITK deficiency disrupts a signaling protein that helps T cells respond after they recognize a threat. Without enough working ITK, calcium signaling and IL-2 production can be reduced, so T cells may not multiply or coordinate a strong defense.
Why can Epstein-Barr virus be especially dangerous with ITK deficiency?
T cells with ITK deficiency may not expand quickly enough to control EBV-infected B cells. The virus can persist and contribute to severe inflammation such as hemophagocytic lymphohistiocytosis, or HLH, and in some cases lymphoma.
What immune-cell changes are common in ITK deficiency?
Many affected children have very low or absent invariant natural killer T cells, low CD4 helper T-cell counts, and less effective CD8 killer T-cell function. Regulatory T-cell levels can vary, so the balance of immune activation and control is not the same in every child.
How is ITK deficiency distinguished from XLP1 and other similar disorders?
Doctors compare the child’s clinical history with genetic sequencing, flow cytometry, and functional immune tests. The genes and mechanisms differ among ITK deficiency, XLP1, XIAP, CD27, and CD70 deficiencies, and flow cytometry alone cannot confirm these diagnoses.
Can a genetic test confirm ITK deficiency?
Genetic testing can identify disease-causing changes in the ITK gene and establish the inherited cause of the immune problem. Doctors may combine sequencing with tests of ITK protein, immune-cell markers, and T-cell function because one test alone may not show the full picture.
What does having very low or absent iNKT cells mean for my child?
iNKT cells help recognize certain threats and support immune responses. Their near absence in ITK deficiency may contribute to difficulty controlling some viral infections, but the child’s overall risk depends on the full immune and genetic evaluation.

Get notified when new evidence is published on Combined immunodeficiency due to ITK deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response.

    Andreotti AH, Joseph RE, Conley JM, et al.

    Annual review of immunology 2018; (36()):549-578 doi:10.1146/annurev-immunol-042617-053344.

    PMID: 29677469
  2. 2

    Itk Promotes the Integration of TCR and CD28 Costimulation through Its Direct Substrates SLP-76 and Gads.

    Hallumi E, Shalah R, Lo WL, et al.

    Journal of immunology (Baltimore, Md. : 1950) 2021; (206(10)):2322-2337 doi:10.4049/jimmunol.2001053.

    PMID: 33931484
  3. 3

    A PLC-γ1 Feedback Pathway Regulates Lck Substrate Phosphorylation at the T-Cell Receptor and SLP-76 Complex.

    Belmont J, Gu T, Mudd A, Salomon AR

    Journal of proteome research 2017; (16(8)):2729-2742 doi:10.1021/acs.jproteome.6b01026.

    PMID: 28644030
  4. 4

    Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.

    Howe MK, Dowdell K, Roy A, et al.

    Frontiers in immunology 2019; (10()):2000 doi:10.3389/fimmu.2019.02000.

    PMID: 31507602
  5. 5

    Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.

    Gallagher MP, Conley JM, Vangala P, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2021; (118(35)) doi:10.1073/pnas.2025825118.

    PMID: 34452995
  6. 6

    Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.

    Eken A, Cansever M, Somekh I, et al.

    Journal of clinical immunology 2019; (39(4)):391-400 doi:10.1007/s10875-019-00632-5.

    PMID: 31025232
  7. 7

    Allele-sensitive mutant, Itkas, reveals that Itk kinase activity is required for Th1, Th2, Th17, and iNKT-cell cytokine production.

    Kannan A, Lee Y, Qi Q, et al.

    European journal of immunology 2015; (45(8)):2276-85 doi:10.1002/eji.201445087.

    PMID: 25989458
  8. 8

    Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis.

    Ogishi M, Yang R, Rodriguez R, et al.

    The Journal of experimental medicine 2023; (220(1)) doi:10.1084/jem.20220484.

    PMID: 36326697
  9. 9

    The kinase ITK controls a Ca2+-mediated switch that balances TH17 and Treg cell differentiation.

    Anannya O, Huang W, August A

    Science signaling 2024; (17(846)):eadh2381 doi:10.1126/scisignal.adh2381.

    PMID: 39042726
  10. 10

    Inducible T Cell Kinase Regulates the Acquisition of Cytolytic Capacity and Degranulation in CD8+ CTLs.

    Kapnick SM, Stinchcombe JC, Griffiths GM, Schwartzberg PL

    Journal of immunology (Baltimore, Md. : 1950) 2017; (198(7)):2699-2711 doi:10.4049/jimmunol.1601202.

    PMID: 28213500
  11. 11

    Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.

    Latour S, Fischer A

    Immunological reviews 2019; (291(1)):174-189 doi:10.1111/imr.12791.

    PMID: 31402499
  12. 12

    Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?

    Ghosh S, Drexler I, Bhatia S, et al.

    Frontiers in immunology 2018; (9()):979 doi:10.3389/fimmu.2018.00979.

    PMID: 29867957
  13. 13

    Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.

    Lechner KS, Neurath MF, Weigmann B

    Journal of molecular medicine (Berlin, Germany) 2020; (98(10)):1385-1395 doi:10.1007/s00109-020-01958-z.

    PMID: 32808093
  14. 14

    Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1.

    Wu L, Yang F, Wang J, et al.

    Molecular genetics & genomic medicine 2022; (10(3)):e1873 doi:10.1002/mgg3.1873.

    PMID: 35092357
  15. 15

    X-Linked Lymphoproliferative Disease in Latvia: A Report of Two Clinically Distinct Cases.

    Nokalna I, Kreile M, Butane D, et al.

    Case reports in medicine 2020; (2020()):7108657 doi:10.1155/2020/7108657.

    PMID: 32774386
  16. 16

    Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.

    Yang L, Booth C, Speckmann C, et al.

    The Journal of allergy and clinical immunology 2022; (150(2)):456-466 doi:10.1016/j.jaci.2021.10.037.

    PMID: 34920033
  17. 17

    Insights into the Absence of Lymphoma Despite Fulminant Epstein-Barr Virus Infection in Patients with XIAP Deficiency.

    Sun Y, Chou J, Dong K, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.01.17.633616.

    PMID: 39868266
  18. 18

    Distinct EBV-Associated Phenotypes Due to a Novel Homozygous Missense Variant in CD27.

    Yang R, Turunbedu SK, Nandiwada S, et al.

    bioRxiv : the preprint server for biology 2026; doi:10.64898/2026.01.15.698722.

    PMID: 41607518
  19. 19

    Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.

    Alkhairy OK, Perez-Becker R, Driessen GJ, et al.

    The Journal of allergy and clinical immunology 2015; (136(3)):703-712.e10.

    PMID: 25843314
  20. 20

    Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.

    Abolhassani H, Edwards ES, Ikinciogullari A, et al.

    The Journal of experimental medicine 2017; (214(1)):91-106 doi:10.1084/jem.20160849.

    PMID: 28011864
  21. 21

    Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.

    Izawa K, Martin E, Soudais C, et al.

    The Journal of experimental medicine 2017; (214(1)):73-89 doi:10.1084/jem.20160784.

    PMID: 28011863
  22. 22

    From T-cell defect to tumorigenesis: Epstein-Barr virus-associated smooth muscle tumors in ITK deficiency.

    Oussama K, Idrissi Fawzi F, Benhsaien I, et al.

    Clinical and experimental immunology 2026; (220(1)) doi:10.1093/cei/uxag028.

    PMID: 42132280

This page explains ITK deficiency and related immune disorders for informational purposes only and does not constitute medical advice. Your child’s immunology and genetics team should interpret test results and guide care.

Guide contents Combined immunodeficiency due to ITK deficiency
Research & Literature
01 Understanding Your Child's ITK Deficiency Diagnosis 03 Symptoms, Complications, and Warning Signs